Microsomal function in biliary obstructed rats: Effects of S-adenosyl-methionine

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 353-359

  Pastor, Ana ^b   Collado, Pilar S ^b   Almar, Mar ^b   González Gallego, Javier ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b NONE

Author keywords

Biliary obstruction; Cytochrome P 450; Membrane fluidity; Microsomal function; S adenosylmethionine

Indexed keywords

CYTOCHROME P450; DEMETHYLASE; METHYLTRANSFERASE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; CONTROLLED STUDY; LIVER PROTECTION; MALE; MEMBRANE FLUIDITY; MICROSOME MEMBRANE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLESTASIS; CYTOCHROME P-450 ENZYME SYSTEM; GLUTATHIONE; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MEMBRANE FLUIDITY; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RATS, WISTAR; S-ADENOSYLMETHIONINE; SPECTROMETRY, FLUORESCENCE;

EID: 0029917936     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80016-X     Document Type: Article

References (40)

1. Hunt DR. The identification of risk factors and their application to the management of obstructive jaundice. Aust N J Surg 1980; 50: 476-80.
2. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65: 305-11.
3. Zimmermann H, Reichen J. Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the rat. J Hepatol: 1992; 16: 355-9.
4. Friedel HA, Goa KL, Benfield P. S-adenosylmethionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989; 38: 389-416.
5. Corrales F, Giménez A, Alvarez L, Caballería J, Pajares MA, Andreu H, Parés A, Mato JM, Rodés J. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 1992; 16: 1022-7.
6. Muriel P, Mourelle M. Characterization of membrane fraction lipid composition and function of cirrhotic rat liver. Role of S-adenosylmethionine. J Hepatol 1992; 14: 16-21.
7. Lucas R, Moran D, Fernández E, Galán AI, Munoz ME, Jiménez R. Ability of S-adenosylmethionine to antagonize cyclosporine A-induced inhibition of the biliary excretion of glutathione. J Hepatol 1994; 21: S87.
8. Stramentinoli G, Di Padova C, Gualano M, Rovagnaty P, Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosylme-thionine and its implication in estrogen metabolism. Gastroenterology 1981; 80: 154-8.
9. Villa JG, Almar MM, Collado PS, Llamazares E, González-Gallego J. Impairment of bile secretion induced by exhaustive exercise in the rat: protective effect of S-adenosylmethionine. Int J Sports Med 1993; 14: 179-84.
10. Belli DC, Founder LA, Lepage G, Yousef I, Roy CC. S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat. J Hepatol 1994; 21: 18-23.
11. Ponsoda X, Jover R, Gómez-Lechon MJ, Fabra R, Trullenque R, Castell JV. Intracellular glutathione in human hepatocytes incubated with S-adenosylmethionine and GSH-depleting drugs. Toxicology 1991; 70: 293-302.
12. Jover R, Ponsoda X, Fabra R, Castell JV. S-adenosylmethionine prevents intracellular glutathione depletion by GSH-depleting drugs in rat and human hepatocytes. Drug Invest 1992; 4: 46-53.
13. Muriel P, Suarez OR, Gonzalez MP, Zuñiga L. Protective effect of S-adenosylmethionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical study. J Hepatol 1994; 21: 95-102.
14. Melzer E, Krepel Z, Ronen I, Bar-Meir S. Recovery of hepatic clearance and extraction following a release of common bile duct obstruction in the rat. Res Exp Med 1992; 192: 35-40.
15. Ohara N, Jaspan J, Chang SW. Hyperglucagonemia and hyperdynamic circulation in rats with biliary cirrhosis. J Lab Clin Med 1993; 121: 142-7.
16. Gross JB, Reichen J, Zeltner TB, Zimmermann A. The evolution of changes in quantitative liver function tests in the rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology 1987; 7: 457-63.
17. Babany G, Descatoire V, Corbic M, Gendre S, Degott C, Larrey D, Letteron P, Wandscheer JC, Funck-Brentano C, Pessayre D. Regulation of renal cytochrome P-450: effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrosis cirrhosis on hepatic and renal microsomes enzymes. Biochem Pharmacol 1985; 34: 311-20.
18. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 1964; 239: 2370-8.
19. Peterson JA, Ebel RE, O'Keeffe DH. Dual-wavelength stopped-flow spectrophotometric measurement of NADPH-cytochrome P-450 reductase. In: Fleischer S, Packer L, eds. Methods of Enzymology. New York: Academic Press, 1978; 221-7.
20. Imai Y, Ito A, Sato R. Evidence for biochemically different types of vesicles in the hepatic fraction. J Biochem 1966; 60: 417-28.
21. Greenlee WF, Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,4,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther 1978; 205: 596-605.
22. Nash T. The colorimetric determination of formaldehyde by means of the Hautzsch reaction. J Biol Chem 1953; 239: 416-21.
23. Shinitzki M, Barenhold Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 1978; 515: 367-94.
24. Hissin P.J, Hilf R. A fluorimetric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-26.
25. Ohkawa H, Ohnishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Pholin phenol reagent. J Biol Chem 1951; 193: 265-75.
27. Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992; 103: 1625-9.
28. Viña J, Gimenez A, Puertes IR, Gasco I, Vina JR. Impairment of cystheine synthesis from methionine in rats exposed to surgical stress. Br J Nutr 1992; 68: 421-9.
29. Ziegler DM. Detoxication: oxidation and reduction. In: Arias IM, Boyer JM, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York: Raven Press, 1994: 415-28.
30. Nakashima T, Shima T, Sakamoto Y, Nakajima T, Seto Y, Sabno A, Iwai M, Okanoue T, Kashima K. Effects of bile acids and taurine on the lipid fluidity of hepatic microsomes in normal and bile duct-ligated rats. A spin label study. J Hepatol 1993; 18: 74-9
31. Vitale GC, Siow Y, Baker PR, Cuschieri A. Reversible bile acid changes in bile duct obstruction and its potential for hepatocellular injury. J Hepatol 1992; 14: 151-6.
32. Dueland S, Reichen J, Everson GT, Davis RA. Regulation of cholesterol and bile acid homeostasis in bile-obstructed rats. Biochem J 1991; 280: 373-7.
33. Oguey D, Marti U, Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for the maintainance of hepatocellular mass. Eur J Cell Biochem 1992; 59: 187-95.
34. Reichen J, Buters JTM, Sojcic Z, Roos FJ. Abnormal lipid composition of microsomes from cirrhotic rat liver. Does it contribute to decreased microsomal function? Experientia 1992; 48: 482-6.
35. Nishiura S, Koga A, Yanagisawa J. Effects of bile duct obstruction and decompression on hepatic microsomal mixed function oxidase system in rats. Exp Mol Pathol 1988; 49: 62-74.
36. Buters JTM, Zysset T, Reichen J. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Biochem Pharmacol 1993; 46: 983-91.
37. Strittmater WJ, Hirata F, Axelrod J. Increased Ca-ATPases activity associated with methylation of phospholipids in human erythrocytes. Biochem Biophys Res Commun 1979; 88: 147-53.
38. Rafique S, Guardascione M, Osman E, Burroughs AK, Owen JS. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver disease by S-adenosylmethionine. Clin Sci 1992; 83: 353-6.
39. Imaoka S, Imai Y, Shimada T, Funae Y. Role of phospholipid in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. Biochemistry 1992; 31: 6063-9.
40. Rietjens IMCM, Ancher LJ, Veeger C. On the role of phospholipids in the reconstituted cytochrome P-450 systems. A model study using dilauroyl and distearoyl glycerophosphocholine. Eur J Biochem 1988; 181: 309-16.